Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Butterfly Network, Inc. (NYSE: BFLY) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings give investors and analysts detailed insight into Butterfly’s financial reporting, corporate actions and material events related to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor technology and digital health software platforms.
Recent Form 8-K filings for BFLY cover several key topics. Some 8-Ks furnish press releases announcing quarterly financial results and preliminary revenue expectations, along with business updates on AI initiatives, chip development milestones and enterprise software such as Compass™ and Compass AI™. Other 8-Ks describe executive leadership changes, including the appointment of a new Chief Financial Officer and related compensation and severance arrangements for finance executives.
Butterfly’s filings also document material agreements. For example, an 8-K dated November 17, 2025 describes a Co-Development and Licensing Agreement with Midjourney, Inc., under which Butterfly grants an exclusive, non-transferable license within a specified field of use to certain Ultrasound-on-Chip technology, software and backend technology, in exchange for specified fees, milestone payments, revenue sharing and chip-related payments. This type of filing helps readers understand how Butterfly’s semiconductor platform is being licensed to partners.
Another notable 8-K, dated January 13, 2026, reports that the New York Stock Exchange has determined to commence proceedings to delist Butterfly’s public warrants (ticker BFLY WS) and suspend trading in those warrants due to "abnormally low selling price" levels under NYSE rules. The filing states that this action does not affect trading in Butterfly’s Class A common stock, which continues on the NYSE under the symbol BFLY.
On Stock Titan, these SEC documents are supplemented with AI-powered summaries that highlight the main points of each filing, helping readers quickly understand topics such as results of operations, material contracts, leadership changes and listing status. Users can review Forms 8-K for event-driven updates, and refer to annual and quarterly reports (Forms 10-K and 10-Q) for broader financial and operational details as they become available through the SEC’s EDGAR system.
Butterfly Network, Inc. executive reports no share ownership. An executive vice president and chief financial officer of Butterfly Network, Inc. filed an initial beneficial ownership statement as an officer of the company. The filing indicates that no Butterfly Network securities are currently beneficially owned, as explicitly stated in the remarks section.
Butterfly Network insider Dr. Jonathan Rothberg filed a notice to sell 176,070 shares of common stock. The shares are to be sold through Jefferies on the NYSE, with an approximate sale date of December 9, 2025, and an indicated aggregate market value of
The shares being sold were originally acquired on August 31, 2014, in a private purchase from Butterfly Network, Inc., paid in cash. The filing also discloses that over the past three months Dr. Rothberg has already sold multiple blocks of common stock, including 1,110,579 shares on November 24, 2025 for gross proceeds of
Butterfly Network, Inc. insider Jonathan M. Rothberg, Ph.D., a director and 10% owner, reported planned stock sales under a Rule 10b5-1 trading plan. The plan was adopted on March 5, 2025 for estate planning purposes.
On December 4, 2025, an affiliated entity, GBR TR, LLC, sold 64,198 shares of Class A common stock at a weighted average price of $3.076 per share, leaving 581,199 Class A shares indirectly held by that entity. On December 5, 2025, GBR TR, LLC sold an additional 37,598 Class A shares at a weighted average price of $3.0744, with 543,601 Class A shares remaining indirectly held.
Rothberg reports indirect beneficial ownership of additional Class A and Class B common stock through multiple family trusts and holding companies and disclaims beneficial ownership beyond his pecuniary interest.
Butterfly Network insider Dr. Jonathan Rothberg filed a notice of proposed sale of 769,327 shares of the company’s common stock. The shares are to be sold through broker Jefferies on the NYSE, with an aggregate market value of
The shares were originally acquired on
Butterfly Network, Inc. director and 10% owner Larry Robbins reported a series of open-market purchases of Class A common stock. On December 3, 2025, entities he oversees bought 821,648 shares at a weighted average price of $2.9619 per share. On December 4, 2025, they bought 536,893 shares at a weighted average of $2.9947, and on December 5, 2025, they bought 200,000 shares at a weighted average of $3.0565.
The shares were acquired by Glenview investment funds, for which Robbins is investment manager, and he shares voting and dispositive power over these holdings. He also has interests through Longview Investors LLC and holds additional securities, including restricted stock units that vest at the company’s 2026 annual stockholders meeting, conditioned on his continued board service.
Butterfly Network insider Dr. Jonathan Rothberg has filed a Form 144 notice to sell 37,598 shares of the company’s common stock through broker Jefferies on the NYSE, with an aggregate market value of $115,591.00. The notice states that 226,200,000 shares of common stock were outstanding, providing a baseline for the company’s total share count.
The shares to be sold were originally acquired on 08/31/2014 in a private purchase from Butterfly Network Inc., paid in cash. The filing also lists prior sales over the past three months, including 100,502 shares sold on 11/03/2025 for gross proceeds of $309,361.24 and 1,110,579 shares sold on 11/24/2025 for $3,503,032.70, along with several additional transactions in late November and early December 2025.
Butterfly Network Inc. insider Dr. Jonathan Rothberg has filed a Form 144 indicating an intention to sell 64,198 shares of the company’s common stock through broker Jefferies on the NYSE, with an approximate sale date of 12/04/2025. These shares were originally acquired on 08/31/2014 via a private purchase from Butterfly Network Inc. for cash. The filing also lists several recent sales of Butterfly Network common stock by Dr. Rothberg during November 2025, each with disclosed share amounts and gross proceeds.
Butterfly Network, Inc. (BFLY)12/02/2025, the officer sold 1,686 shares of Class A common stock. The weighted average sale price was about $2.829 per share, with individual trades executed between $2.79 and $2.87 per share.
The company has a sell-to-cover policy for tax withholding, and these sales represent shares automatically sold to satisfy tax obligations tied to vesting restricted stock units. After this transaction, the reporting person beneficially owned 231,035 shares of Butterfly Network stock, held directly.
Butterfly Network, Inc.$3.079 per share through JNR TR, LLC. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025 for estate planning purposes, with individual trade prices ranging from $3.07 to $3.105 per share.
After this transaction, Rothberg continues to beneficially own substantial stakes in Butterfly Network’s Class A and Class B common stock through multiple entities, including JNR TR, LLC, EJR TR, LLC, GBR TR, LLC, NVR TR, LLC and several 4C Holdings entities, as well as through his spouse.
A BFLY shareholder filed a Form 144 notice to sell 1,686 Class A shares through Fidelity Brokerage Services on the NYSE, with an indicated aggregate market value of $4,769.02. The filing notes that 226,175,175 Class A shares were outstanding at the time. The shares to be sold were acquired on 12/01/2025 via restricted stock vesting from the issuer as compensation, with payment also dated 12/01/2025. Over the prior three months, the same seller disposed of 1,724 Class A shares for gross proceeds of $2,622.20, reflecting recent ongoing sales activity.